Reviewing Dare Bioscience Inc. (DARE)’s and Baudax Bio Inc. (NASDAQ:BXRX)’s results

Dare Bioscience Inc. (NASDAQ:DARE) and Baudax Bio Inc. (NASDAQ:BXRX) compete with each other in the Biotechnology sector. We will analyze and compare their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation.

Valuation & Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Dare Bioscience Inc. 1 0.00 14.35M -1.02 0.00
Baudax Bio Inc. 6 0.00 N/A -4.62 0.00

Table 1 shows gross revenue, earnings per share (EPS) and valuation of the two companies.

Profitability

Table 2 has Dare Bioscience Inc. and Baudax Bio Inc.’s return on assets, return on equity and net margins.

Net Margins Return on Equity Return on Assets
Dare Bioscience Inc. 1,610,188,509.87% -324.2% -235.2%
Baudax Bio Inc. 0.00% 0% 0%

Liquidity

Dare Bioscience Inc.’s Current Ratio and Quick Ratio are 1.7 and 1.7 respectively. The Current Ratio and Quick Ratio of its competitor Baudax Bio Inc. are 0.3 and 0.3 respectively. Dare Bioscience Inc. therefore has a better chance of paying off short and long-term obligations compared to Baudax Bio Inc.

Institutional & Insider Ownership

Institutional investors held 4.8% of Dare Bioscience Inc. shares and 0% of Baudax Bio Inc. shares. Insiders held roughly 16.92% of Dare Bioscience Inc.’s shares.

Performance

In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Dare Bioscience Inc. 0% -4.36% 3.83% -6.9% -17.35% 14%
Baudax Bio Inc. 24.21% 0% 0% 0% 0% -4.71%

For the past year Dare Bioscience Inc. has 14% stronger performance while Baudax Bio Inc. has -4.71% weaker performance.

Summary

Dare Bioscience Inc. beats on 5 of the 8 factors Baudax Bio Inc.

Daré Bioscience, Inc. develops and commercializes product for women’s reproductive health, Ovaprene. The company was incorporated in 2015 and is based in La Jolla, California.